Novus Biologicals™ CCL23/Ck beta 8-1/MIP3 Recombinant Protein Antigen

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human CCL23. The CCL23/Ck beta 8-1/MIP3 Recombinant Protein Antigen is derived from E. coli. The CCL23/Ck beta 8-1/MIP3 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

This is a blocking peptide for NBP1-88079. This is a human recombinant protein expressed in E. coli with a N-terminal His-ABP tag and purified with IMAC chromatography.

Specifications

• Gene ID (Entrez): 6368
• Species: Human
• Purification Method: Chromatography
• Purity: >80%
• Concentration: 0.5mg/mL
• Content And Storage: Store at -20°C. Avoid freeze-thaw cycles.
• Formulation: PBS and 1M Urea, pH 7.4.
• For Use With (Application): Blocking/Neutralizing, Control
• Gene Alias: C6 beta-chemokine, chemokine (C-C motif) ligand 23, Ckb-8, CKb8, CK-beta-8, hmrp-2a, Macrophage inflammatory protein 3, MIP3, MIP-3CK-BETA-8, MPIF1, MPIF-1Ckb-8-1, Myeloid progenitor inhibitory factor 1, SCYA23C-C motif chemokine 23, small inducible cytokine subfamily A (Cys-Cys), member 23, Small-inducible cytokine A23
• Gene Symbol: CCL23
• Label Type: Unlabeled
• Molecular Weight (g/mol): 24kDa
• Product Type: CCL23/Ck beta 8-1/MIP3
• Quantity: 0.1 mL
• Regulatory Status: RUO
• Source: E.Coli
• Specific Reactivity: This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP1-88079. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
• Immunogen: NPVLLDMLWRRKIGPQMTLSHAAGFHATSADCCISYTPRSIPCSLLESYFETNS

For Research Use Only